
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
So perhaps it's time to step back and take a look at some of what computerization is doing to, and for, the practice of medicine. Ponder the following:






